Allocations
Amicus Finance, a specialist in short term lending solutions, has acquired City-based brokerage Norton Folgate Capital Group Limited including Norton Folgate Capital Consulting for an undisclosed sum.
Amicus has secured an initial stake of 75% in Norton Folgate Capital Consulting LLP with the remaining 25% being held by the incumbent partners.
Amicus has committed significant working capital and resources to build the Norton Folgate business over the next five years to become a strong and sustainable provider in the areas of SME asset finance and leasing, HNWI financing and SME business loans. Norton Folgate will continue to operate
Asahi Kasei Corporation has entered into a definitive merger agreement to acquire Polypore International, a manufacturer of microporous membranes, which currently has two business segments: Energy Storage and Separations Media.
In conjunction with this transaction, Polypore has also entered into a definitive asset purchase agreement to sell the assets and liabilities related to the Separations Media segment to 3M Company (NYSE:MMM, hereinafter: “3M”) for cash consideration of approximately USD 1.0 billion
Asahi Kasei, through a US subsidiary, will acquire all of the outstanding shares of Polypore’s common stock for USD 60.50 per share in the form of a cash merger,
Red Rocks Capital’s Global Listed Private Equity (GLPE) index continues to provide long-term performance comparable with the Cambridge Associates Global Buyout & Growth Equity Index.
GLPE Index has approximately USD500 million in ETF tracking assets, and was the first US-based investable index to monitor global listed private equity companies.
The Cambridge Associates Global Buyout & Growth Equity Index is a widely followed private equity benchmark and is an end-to-end calculation based on data compiled from 1,753 global (US & ex US) buyout and growth equity funds including fully liquidated partnerships, formed between 1986 and 2014.
"Traditional illiquid private equity limited
Baring Private Equity Asia has held the closing of The Baring Asia Private Equity Fund VI, a private equity fund with USUSD3,988,000,000 in commitments.
Fund VI, which reached its first close of USD3.3 billion last year within four months of launching, closed at its hard cap and was heavily oversubscribed. Baring Asia is one of the oldest and most established firms in the region and has been investing in Asia since 1997.
Fund VI will continue the firm’s strategy of partnering with management teams and entrepreneurs to support their growth in Asia through operational improvement, industry consolidation and cross-border
Private equity firm Thoma Bravo has acquired PowerPlan, a provider of accounting, tax and capital budgeting optimisation solutions for capital asset-intensive businesses, from current investors JMI Equity and TPG Growth.
Financial details of the deal have not been disclosed.
“PowerPlan has addressed the information gaps that develop between finance and field operations in asset-centric businesses, and established a market-leading software company that is critical to all of its customers’ operations,” says Scott Crabill, a managing partner at Thoma Bravo.
“It’s exciting to be able to put our software experience and buy and build philosophy to work for PowerPlan,” added Holden
Shore Capital Partners has completed the acquisition of Summit Medical a medical device manufacturer that has been designing, engineering and manufacturing microsurgery products for over 30 years.
In addition to its Instru-Safe instrument protection line for infection control and sterilisation in the critical care market, Summit Medical manufactures ear, nose, and throat (ENT) products and a variety of other surgical products.
A Fast 50 Honoree for 2014, Summit Medical has achieved significant growth over the last several years due to its leading position in the minimally-invasive instrument protection and ENT markets. Kevin McIntosh, President of Summit Medical, and Lorraine Duchene,
Blackstone Group’s Equity Healthcare has selected ConSova Corporation as the preferred dependent eligibility partner for its 40+ affiliated companies.
Through this agreement, ConSova joins forces with Equity Healthcare to offer a full range of health care cost containment solutions to the companies within the Blackstone Group’s global asset management portfolio as well as other affiliated private equity firms. Equity Healthcare’s companies will gain access to best-of-breed solutions for Dependent Eligibility Verification, Working Spouse Provision Audits and Ongoing Verification Services.
Equity Healthcare, a wholly owned subsidiary of The Blackstone Group, leverages the scale of the combined purchasing power of its portfolio
DMS Offshore Investment Services Ltd and White Oak Global Advisors have launched of an Alternative Investment Fund (AIF) hosted on the DMS Irish platform.
White Oak has engaged the DMS AIF platform, which is regulated by the Central Bank of Ireland as an AIFM in Ireland, and by the CSSF in Luxembourg, to access its European investors, taking advantage of the firm's established track record in fund governance and expertise in independent risk management in Europe.
Since the enactment of the Alternative Investment Fund Managers Directive (AIFMD) in 2013, DMS has developed this proprietary AIF Platform to provide investment managers
Hamburg-based shipping company Hamburg Südamerikanische Dampfschifffahrts-Gesellschaft is to buy the container line operations of Chilean shipping line Compañía Chilena de Navegación Interoceánica (CCNI), Valparaiso.
The relevant contracts were signed last weekend. As part of the transaction, Hamburg Süd is also acquiring the agency business of Chilean firm Agunsa Agencias Universales S.A. (Agunsa), which is integral to the container line service.
The CCNI / Agunsa operations are scheduled to be transferred at the end of March 2015, subject to approval from the competition authorities.
A team from CMS in Germany led by Dr Christian von Lenthe (lead partner) and Dr Arne
2014 was one of business angel syndicate Archangels’ most active years for investment in Scottish-based early stage and established technology and life sciences businesses and provided strong levels of returns for investors.
Archangels arranged funding of GBP12.2m for 14 companies, comprising GBP7.5m of investment from Archangels’ investors, with a further GBP3.5m of co-investment from Scottish Enterprise and GBP1.2m from other partners. Archangels’ annual gathering of investors and invested companies will hear that the biggest single investment was GBP2.5m in Scottish bionic prosthetic upper limb producer, Touch Bionics, in May last year.
In 2014, Archangels also invested GBP100,000 in Cytomos,
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
